Tag: schizophrenia treatment advancements

In a groundbreaking advance for psychiatric therapeutics, the recent FDA approval of xanomeline/trospium combination—marketed as Cobenfy—marks a pivotal moment in ...

A groundbreaking study published recently in Nature Mental Health sheds new light on the real-world efficacy of a revolutionary drug ...

In a groundbreaking study poised to reshape the treatment landscape for schizophrenia, researchers at Case Western Reserve University's Jack, Joseph ...

In recent years, the treatment landscape for schizophrenia has witnessed significant advancements, especially concerning the development of long-acting injectable antipsychotics. ...

In the continuously evolving landscape of psychiatric treatment, the quest for antipsychotic medications that deliver efficacy without the burden of ...

The realm of schizophrenia treatment has witnessed a compelling advancement with recent research highlighting the potential of paliperidone palmitate once-monthly ...

In recent years, the pursuit of novel treatments for schizophrenia has increasingly focused on targeting the glutamatergic system, particularly the ...